Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Poly MedicureNSE:POLYMED +0.78%91 Days Payable is 62.83 as of Mar. 2026, which is 4% below its 10-year median of 65.43. GuruFocus rates NSE:POLYMED with a GF Score™ of 91/100 and a GF Value™ of ₹2,324.42 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Poly Medicure ranks worse than 64.78% on this metric.
The historical rank and industry rank for Poly Medicure's Days Payable or its related term are showing as below:
NSE:POLYMED'
s Days Payable Range Over the Past 10 Years
Min: 52.62 Med: 65.43 Max: 77.88
Current: 52.62
During the past 13 years, Poly Medicure's highest Days Payable was 77.88. The lowest was 52.62. And the median was 65.43.
NSE:POLYMED's Days Payable is ranked worse than 64.78% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs NSE:POLYMED: 52.62
Poly Medicure's Days Payable
increased
from Mar. 2025 (53.23) to Mar. 2026 (62.83).
It may suggest that Poly Medicuredelayed paying its suppliers.
Poly Medicure Days Payable Related Terms
Poly Medicure Days Payable Historical Data
* Premium members only.
The historical data trend for Poly Medicure's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:POLYMED vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Poly Medicure's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poly Medicure Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Days Payable distribution charts can be found below:
* The bar in red indicates where Poly Medicure's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Poly Medicure's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Poly Medicure (NSE:POLYMED) has a Days Payable of 62.83 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Poly Medicure and its competitors. This is near median its historical median of 65.43. Over the past decade, Poly Medicure's Days Payable has ranged from 52.62 to 77.88. According to the industry distribution chart, Poly Medicure ranks #515 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 64.8%.
Is Poly Medicure's Days Payable too high?
Poly Medicure's current Days Payable of 62.83 is near median its 10-year median of 65.43. Over the past 10 years, this metric has ranged from a low of 52.62 to a high of 77.88. The Medical Devices & Instruments industry median Days Payable is 67.87. Poly Medicure's value of 62.83 is 7.4% below this industry median. Based on the distribution chart, Poly Medicure ranks #515 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Poly Medicure has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Poly Medicure ranks #515 out of 795 companies for Days Payable. This places Poly Medicure in the lower half of its industry. The industry median Days Payable is 67.87. Poly Medicure's value of 62.83 is 7.4% below this benchmark. Historically, Poly Medicure's own Days Payable has ranged from 52.62 to 77.88 over the past decade. While the company's 10-year median is 65.43 vs. the industry median of 67.87, Poly Medicure has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Poly Medicure's current Days Payable of 62.83 is 7.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Poly Medicure and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poly Medicure's current Days Payable is 62.83, which is near median its own 10-year median of 65.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (NSE:POLYMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,324.42, compared to a current price of ₹1,664.40 — trading 28.4% below its estimated fair value. The current Days Payable is 62.83, which is near median its 10-year median of 65.43 and 7.4% below the Medical Devices & Instruments industry median of 67.87. Poly Medicure's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Poly Medicure (NSE:POLYMED), the current Days Payable is 62.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?
Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued.
The current stock price of ₹1,664.40 is trading 28.4% below its estimated GF Value™ of ₹2,324.42.
GuruFocus considers Poly Medicure to be Modestly Undervalued.
Key valuation signals for NSE:POLYMED:
Days Payable: 62.83 (near median its 10-year median of 65.43)
GF Value™: ₹2,324.42 vs. price of ₹1,664.40 (28.4% below fair value)
Industry Position: 7.4% below the Medical Devices & Instruments median (#515 of 795)
No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
91GF Score
Get the complete analysis for NSE:POLYMED
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:POLYMED has been successfully added to your 
